Rasagiline, a propargylamine derivative, functions as a monoamine oxidase type B (MAO-B) inhibitor in the treatment of Parkinsons disease. Administered orally, it prevents the breakdown of dopamine, increasing its levels in the brain and thereby alleviating symptoms associated with Parkinsons disease. Rasagiline is recognized for its neuroprotective effects and is often prescribed as part of a comprehensive approach to manage the progression of motor dysfunction in Parkinsons patients, either as monotherapy or in combination with other medications. Buy high quality Rasagiline tartrate from Chemicea Pharmaceuticals. Chemicea Pharmaceuticals is one of the leading manufacturer and exporter of Rasagiline tartrate